Application-specific formulations (e.g., PRF, with bone graft)

About Regenlab USA

Regenlab USA is a subsidiary of the Swiss-based Regenlab group, a pioneer in the standardized PRP and regenerative medicine device market. The company provides a portfolio of CE-marked and FDA-cleared medical devices that automate the preparation of autologous biological products, aiming to improve reproducibility and clinical outcomes. Its business model revolves around selling proprietary single-use kits and associated centrifuges to clinics and hospitals, generating revenue from consumables. Operating as a private entity, Regenlab has established a commercial presence globally, positioning itself in the growing field of orthobiologics and minimally invasive regenerative procedures.

Therapeutic Areas